Company

Rejoni, Inc.

Rejoni develops medical products to prevent intrauterine adhesions after uterine procedures.

About

Founded in 2020 and based in Bedford, Massachusetts, Rejoni is developing Juveena Hydrogel to reduce scar tissue after uterine surgery. In June 2026, the company raised USD 25 million from ClavystBio, with participation from AMED Ventures, Ascension Ventures, Catalyst Health Ventures, Delos Capital, FemHealth Ventures, Iyengar Capital Partners and Sparta Group.

3Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in